Long-term follow up of metastatic melanoma patients treated with Thymosin alpha-1: investigating immune checkpoints synergy.

Danielli, Riccardo et al.·Expert opinion on biological therapy·2018·
RPEP-036382018RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Long-term follow up of metastatic melanoma patients treated with Thymosin alpha-1: investigating immune checkpoints synergy.
Published In:
Expert opinion on biological therapy, 18(sup1), 77-83 (2018)
Database ID:
RPEP-03638

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-03638·https://rethinkpeptides.com/research/RPEP-03638

APA

Danielli, Riccardo; Cisternino, Filomena; Giannarelli, Diana; Calabrò, Luana; Camerini, Roberto; Savelli, Vinno; Bova, Giovanni; Dragonetti, Rosella; Di Giacomo, Anna Maria; Altomonte, Maresa; Maio, Michele. (2018). Long-term follow up of metastatic melanoma patients treated with Thymosin alpha-1: investigating immune checkpoints synergy.. Expert opinion on biological therapy, 18(sup1), 77-83. https://doi.org/10.1080/14712598.2018.1494717

MLA

Danielli, Riccardo, et al. "Long-term follow up of metastatic melanoma patients treated with Thymosin alpha-1: investigating immune checkpoints synergy.." Expert opinion on biological therapy, 2018. https://doi.org/10.1080/14712598.2018.1494717

RethinkPeptides

RethinkPeptides Research Database. "Long-term follow up of metastatic melanoma patients treated ..." RPEP-03638. Retrieved from https://rethinkpeptides.com/research/danielli-2018-longterm-follow-up-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.